Clinical Trial Update: UMIT-1 Trial Favipiravir & Ribavirin for the Treatment of CCHF [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for UMIT-1 evaluating favipiravir and ribavirin in caring for Crimean-Cocol? Crimean-Congo hemorrhagic fever (CCHF) across Phase 1 and Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crimean-congo Hemorrhagic Fever

Drugs mentioned

• Favipiravir (favipiravir)
• Ribavirin (ribavirin)

Snippet

Sponsor: Liverpool School of Tropical Medicine | Conditions: CCHF | Phase 1, Phase 2 | Status: UNKNOWN